These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine. Griffiths JD; Stark RJ; Ding JC; Cooper IA Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012 [TBL] [Abstract][Full Text] [Related]
7. [Severe acute neuropathy caused by vincristine. A new case]. Dubois A; Reynaud D; Yeche S; Lorenzo S Therapie; 1993; 48(5):515. PubMed ID: 8146850 [No Abstract] [Full Text] [Related]
8. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia. Baker SK; Lipson DM J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233 [TBL] [Abstract][Full Text] [Related]
9. Discordance in the development of peripheral and autonomic neuropathy during vincristine therapy. Lahtinen R; Koponen A; Mustonen J; Soppi E; Länsimies E; Nousiainen T; Lahtinen R Eur J Haematol; 1989 Oct; 43(4):357-8. PubMed ID: 2555214 [No Abstract] [Full Text] [Related]
10. An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia. Stock W; Diouf B; Crews KR; Pei D; Cheng C; Laumann K; Mandrekar SJ; Luger S; Advani A; Stone RM; Larson RA; Evans WE Clin Pharmacol Ther; 2017 Mar; 101(3):391-395. PubMed ID: 27618250 [TBL] [Abstract][Full Text] [Related]
11. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma. Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108 [TBL] [Abstract][Full Text] [Related]
12. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X. Porter CC; Carver AE; Albano EA Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430 [TBL] [Abstract][Full Text] [Related]
13. Mononeuropathy due to vincristine toxicity. Levitt LP; Prager D Neurology; 1975 Sep; 25(9):894-5. PubMed ID: 169494 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial. Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405 [TBL] [Abstract][Full Text] [Related]
15. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658 [TBL] [Abstract][Full Text] [Related]
16. [Biochemical studies of experimental vincristine neuropathy. Lipid changes of proximal and distal peripheral nerve tissue]. Saito T; Kowa H; Ishikawa K; Torii J; Tazaki Y Rinsho Shinkeigaku; 1984 Jul; 24(7):657-64. PubMed ID: 6094072 [No Abstract] [Full Text] [Related]